Skip to content

Study on treatment of traditional Chinese medicine of drug-induced liver injury: a randomized controlled trial.

Study on treatment of traditional Chinese medicine of anti-tuberculosis drug-induced liver injury

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000032581
Enrollment
Unknown
Registered
2020-05-03
Start date
2020-05-08
Completion date
Unknown
Last updated
2020-05-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Drug-induced liver injury

Interventions

Sponsors

Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Those who meet the diagnostic criteria for tuberculosis and have abnormal liver function after applying anti-tuberculosis drugs; 2. The severity of DILI is graded 1-2; 3. The age range is between 18-75 years old; 4. Not taking other drugs to protect liver and reduce enzyme, Or has been suspended for more than 2 weeks; 5. Signed informed consent voluntarily.

Exclusion criteria

Exclusion criteria: 1. The liver function test before medication is elevated in alanine aminotransferase or bilirubin, and any of them is> 2 times the upper limit of normal value; 2. People with HIV infection, the original history of viral hepatitis or serological signs of hepatitis Those with positive substance; 3. Combined with serious primary diseases such as cardiocerebrovascular, kidney, hematopoietic system, peptic ulcer, or serious diseases (such as tumors) that affect their survival, or patients with mental or legal disabilities; 4. Do have a history of alcohol and drug abuse; 5. Allergic constitution, or known to be allergic to the drug components in the test protocol; 6. Pregnant, pregnant or lactating women.

Design outcomes

Primary

MeasureTime frame
Liver function;TCM syndrome points;Life quality assessment;

Secondary

MeasureTime frame
Immune function test;Coagulation test;Renal function;

Countries

China

Contacts

Public ContactFeng Jiang

Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine

jiangfengtcm@163.com+86 13811808029

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026